JSM 2005 Online Program

JSM Activity #361

This is the preliminary program for the 2005 Joint Statistical Meetings in Minneapolis, Minnesota. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 7-10, 2005); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.

The Program has labeled the meeting rooms with "letters" preceding the name of the room, designating in which facility the room is located:

Minneapolis Convention Center = “MCC” Hilton Minneapolis Hotel = “H” Hyatt Regency Minneapolis = “HY”

Back to main JSM 2005 Program page

Legend:

= Applied Session,

= Theme Session,

= Presenter


		Add To My Program
361	Wed, 8/10/05, 8:30 AM - 10:20 AM	MCC-200 I
Drug CombinationStudies and Design of Clinical Trials - Contributed - Papers
Biopharmaceutical Section, WNAR
Chair(s): Xiaohui Luo, Merck & Co., Inc.
8:35 AM	Experimental Design for Testing Synergism in Drug Combination Studies — Hongbin Fang, University of Maryland; Ming Tan, University of Maryland
8:50 AM	Optimal Experimental Designs for Drug Synergism Studies — Donald White, The University of Toledo; William R. Greco, Roswell Park Cancer Institute
9:05 AM	A Semiparametric Response Surface Model for Assessing Drug Interaction as Synergy, Additivity, or Antagonism — Maiying Kong, The University of Texas M. D. Anderson Cancer Center; J. Jack Lee, The University of Texas M. D. Anderson Cancer Center
9:20 AM	Flexible Multi-stage Study Design for Single-arm, Phase-II Clinical Trials — Muhammad Jalaluddin, Pfizer, Inc.; Enayet Talukder, Pfizer, Inc.
9:35 AM	Statistical Consideration of Group Sequential Method — Huaixiang Li, U.S. Food and Drug Administration; Yi Tsong, U.S. Food and Drug Administration
9:50 AM	Significant Design Components in General Two-stage Adaptive Procedures — Tatsuki Koyama, Vanderbilt University; Allan R. Sampson, University of Pittsburgh; Leon J. Gleser, University of Pittsburgh
10:05 AM	Designs for Phase-II Window Studies — Myron Chang, University of Florida; Meenakshi Devidas, University of Florida; James Anderson, University of Nebraska